- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Patent holdings for IPC class A61K 47/26
Total number of patents in this class: 8616
10-year publication summary
|
552
|
684
|
805
|
831
|
967
|
1029
|
1184
|
1120
|
1034
|
356
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 3650 |
73 |
| Amgen Inc. | 3779 |
65 |
| Takeda Pharmaceutical Company Limited | 2961 |
65 |
| Novartis AG | 11238 |
62 |
| Azurity Pharmaceuticals, Inc. | 147 |
56 |
| Genentech, Inc. | 3742 |
53 |
| Allergan, Inc. | 2600 |
52 |
| Coherus Biosciences, Inc. | 172 |
50 |
| Daiichi Sankyo Company, Limited | 1829 |
49 |
| Pfizer Inc. | 3322 |
41 |
| Chiesi Farmaceutici S.p.A. | 940 |
40 |
| Alkermes Pharma Ireland Limited | 307 |
39 |
| Astellas Pharma Inc. | 1145 |
38 |
| Chugai Seiyaku Kabushiki Kaisha | 1259 |
37 |
| Merck Sharp & Dohme LLC | 3689 |
37 |
| F. Hoffmann-La Roche AG | 7958 |
33 |
| Hoffmann-La Roche Inc. | 3060 |
33 |
| Hanmi Pharm. Co., Ltd. | 546 |
30 |
| Janssen Biotech, Inc. | 1347 |
30 |
| Crititech, Inc. | 76 |
29 |
| Other owners | 7704 |